I can't get a dialling tone microzide manufacturer MCK's stable margins, efficient operations, and good asset management contribute to stable and strong cash generation measures. Funds from operations (FFO) for the latest 12 months (LTM) period ended June 30, 2013 was a robust $3 billion. Annual free cash flow is forecasted to exceed $2 billion over the ratings horizon, though this figure is highly dependent on working capital swings inherent in drug distributors operating profiles.
